Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arizona for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arizona only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arizona (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Joy Schechtman (NPI 1649244716)

Field	Value
Entity Type	Individual
Organization	Joy Schechtman
Address	6818 W Thunderbird Rd
City	Peoria
State	AZ
ZIP	85381
Taxonomy	Rheumatology Physician
NPI Enumerated	February 15, 2006

Payer Source	Total Paid
Medicare	$7.8M
Medicaid	$0

Key Findings

This provider’s Medicare activity is heavily driven by onsite administration of biologic and infused therapies: the top three Medicare revenue codes are J0129 (abatacept, 18.6%), J1602 (golimumab, 12.8%), and J0717 (certolizumab pegol, 12.4%), and those top 3 codes account for 43.8% of total Medicare revenue. The code mix (multiple high-volume J-codes for injectable biologics plus high-ranking infusion/chemotherapy administration codes such as 96413 and 96415) indicates a practice structured around drug administration and infusion services rather than solely office-based evaluation.

The provider’s scale on Medicare is material: Total Medicare revenue is $7.8M while Total Medicaid revenue is none (no Medicaid billing on file), making the practice effectively single-payer with Medicare as the dominant revenue source. That payer concentration should be considered when modeling payer-risk or contracting strategies because there is no Medicaid footprint to offset Medicare exposure.

Several individual drug codes show national dominance, signaling an unusually large infusion business. J1602 ranks #5 of 1041 providers nationally (100th percentile; extreme outlier), J0129 ranks #10 of 1221 (99th percentile; extreme outlier), and J0717 ranks #16 of 848 (98th percentile; notably above typical national volume for this code), which together point to volumes far above typical peers for multiple high-cost injectable biologics.

Beyond the top three, the provider reports similarly elevated volumes for other infusion biologics — for example, J3262 (tocilizumab) ranks #12 of 618 providers nationally (98th percentile; extreme outlier) and J1745 (infliximab) ranks #9 of 1352 providers nationally (99th percentile; extreme outlier). These multiple high-percentile positions across different biologics suggest the practice is a regional or national outlier in delivering a broad portfolio of infused rheumatology therapies rather than concentrating on a single agent.

Office-based E/M activity is also notable and supports substantial outpatient management: 99214 appears with 4K claims and $365.4K revenue and ranks #75 of 479517 providers nationally (100th percentile; extreme outlier), indicating a high volume of moderate-complexity follow-up visits consistent with ongoing biologic management and infusion follow-up. This mix of high E/M visits plus infusion throughput suggests integrated care where monitoring and drug administration are both revenue drivers.

Infusion administration and chemotherapy administration codes are unusually prominent for a rheumatology taxonomy: 96413 ranks #4 of 7514 providers nationally (100th percentile; extreme outlier) and 96415 ranks #21 of 4959 providers nationally (100th percentile; extreme outlier). Presence of these add-on and initial infusion codes, together with high-volume J-codes, implies significant chair/infusion capacity and support staff on site.

The practice shows complementary procedural and diagnostic services consistent with rheumatologic care: high ranks on arthrocentesis with ultrasound guidance (20611 ranks #123 of 8465, 99th percentile; extreme outlier) and bone density testing (77080 ranks #413 of 17308, 98th percentile; notably above typical national volume). These items reinforce a service-line that blends drug infusions, joint procedures, and osteoporosis management rather than a narrow procedure set.

The provider’s NPI has been enumerated since 2006-02-15 (~20 years ago), indicating long tenure in Medicare billing. Combined with extreme national outlier ranks on multiple infusion and administration codes, this tenure supports the interpretation of an established infusion-focused rheumatology practice with sustained high Medicare dependency and no Medicaid billing on file.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

31 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	42,720	$30	$1.5M
J1602	Injection, golimumab, 1 mg, for intravenous use	99,940	$10	$999.4K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	241,200	$1	$964.8K
J3262	Injection, tocilizumab, 1 mg	165,020	$10	$825.1K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	24,910	$30	$647.6K
J3111	Injection, romosozumab-aqqg, 1 mg	76,240	$10	$609.9K
J0897	Injection, denosumab, 1 mg	33,720	$20	$607K
J0491	Injection, anifrolumab-fnia, 1 mg	42,630	$10	$554.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	3,970	$90	$365.4K
J9312	Injection, rituximab, 10 mg	4,500	$60	$283.5K

Showing 1–10 of 31

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 31 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arizona Distribution

Joy Schechtman — 12 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arizona

Full comparison — all codes billed, vs. state median

31 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0491	1	10	42,630	$10	$550.1K
J0129	1	30	14,700	$30	$494.5K
J3262	3	20	74,500	$1	$367.2K
J1602	1	30	24,040	$10	$316.2K
J0717	1	20	36,100	$1	$246.6K
J9312	3	20	3,250	$60	$212.6K
J3111	2	40	19,530	$10	$178.8K
J0897	7	260	2,940	$20	$115.6K
J1745	1	40	2,980	$30	$103.9K
96413	1	230	190	$100	$24.8K

Showing 1–10 of 31

Nearby Providers

Other providers in the same ZIP code as Joy Schechtman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Pain Center Of Arizona PC	AZ	Interventional Pain Medicine Physician	$0	$21.3M
Arizona Dental Anesthesia PLLC	AZ	Dental Anesthesiology	$0	$11M
Dvma, LLC	AZ	Internal Medicine Physician	$0	$9.7M
Surgery Center Of Peoria, LLC	AZ	Ambulatory Surgical Clinic/Center	$408.4K	$7M
Phoenix Medical Group, P.C.	AZ	Pulmonary Disease Physician	$0	$7M
Joshua Holland	AZ	Family Medicine Physician	$5.1M	$0
Ravi Bhalla	AZ	Rheumatology Physician	$2.8M	$435.8K
Ski Ambulatory Surgical Centers, LLC	AZ	Ambulatory Surgical Clinic/Center	$1.1M	$1.7M
Jason Samuelian	AZ	Radiation Oncology Physician	$2.1M	$0
Terry Lee	AZ	Radiation Oncology Physician	$1.2M	$0

Joy Schechtman — Billing Profile & Reimbursement Data

Sign up for Joy Schechtman — Billing Profile & Reimbursement Data policy alerts

Joy Schechtman — Billing Profile & Reimbursement Data

Sign up for Joy Schechtman — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References